Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Bipolar Disord. 2021 Jul 23;24(2):161–170. doi: 10.1111/bdi.13110

Figure 2.

Figure 2.

CDRS-R (A) and CGI-S (B) total scores at baseline and following 12-week supplementation with FO or placebo. Data are expressed as group mean ± S.E.M. ***P≤0.0001 vs. Baseline, #P≤0.01 vs. Placebo week 12.